Sphingosine kinase 2 (SPHK2) can activate HDAC through the production of S1P, leading to histone H3K9 deacetylation and epigenetic remodeling of PASMCs, thereby promoting PAH vascular remodeling. The gene discussed is HDAC9; the disease is pulmonary arterial hypertension.